Biomedical Research Institute of Southern California
Biomedical Research Institute of Southern California
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Daffy covers the bank/ACH transaction fees so 100% of your donation goes to your favorite charities. Daffy also waives fees for your first credit or debit card donation up to $1,000. After that, there is a 2.9% surcharge to cover fees charged by payment processors.
Do you work for Biomedical Research Institute of Southern California? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
More about this organization
Mission
To conduct basic and translational biomedical research aimed at understanding, preventing or curing human disease.
About
Viral immunology. The objective of this program is to conduct research into the mechanisms by which the immune system protects us against viral infections. This research will help us to develop better vaccines and therapeutic agents for viral infections. In addition, it will assist in the design of better immunosuppressive drugs to prevent transplant rejection and autoimmunity, without compromising immunity to viral infections. This program includes pre-clinical research on novel universal influenza vaccine, funded by the National Institutes of Health. Influenza causes an average of 36,000 deaths and 200,000 hospitalizations per year in the U.S., while global pandemics have previously killed over 50 million people. We have confirmed that, unlike current vaccines, this novel vaccine provides effective protection against multiple different strains of influenza. Our goals are to evaluate the possible side effects, to determine the mechanism by which the vaccine protects against multiple influenza strains, and to determine whether the vaccine prevents secondary bacterial infections that often significantly increase mortality.
